Lakefront Biotherapeutics
LKFT
#4601
Rank
NZ$3.98 B
Marketcap
NZ$60.89
Share price
-0.24%
Change (1 day)
N/A
Change (1 year)

EPS for Lakefront Biotherapeutics (LKFT)

EPS in 2026 (TTM): NZ-$0.93

According to Lakefront Biotherapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.74. In 2025 the company made an earnings per share (EPS) of NZ$10.46 an increase over its 2024 EPS that were of NZ$2.13.

EPS history for Lakefront Biotherapeutics from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-108.86%
2025NZ$10.46390.86%
2024NZ$2.13-67.16%
2023NZ$6.49-199.64%
2022NZ-$6.5199.03%
2021NZ-$3.27-68.98%
2020NZ-$10.55-298.06%
2019NZ$5.32-554.64%
2018NZ-$1.17-77.18%
2017NZ-$5.13-326.21%
2016NZ$2.27-134.19%
2015NZ-$6.64-371.34%
2014NZ$2.45-445.98%
2013NZ-$0.7132.88%
2012NZ-$0.53-82.07%
2011NZ-$2.97-817.9%
2010NZ$0.4112.73%
2009NZ$0.37-120.79%
2008NZ-$1.76-37.67%
2007NZ-$2.8339.64%
2006NZ-$2.0328.17%
2005NZ-$1.586.25%
2004NZ-$1.49